Angiotensin II Blockade and Inflammation in Obesity
NCT01684748
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Overweight
Obese
Prehypertension
Hypertension
Interventions
DRUG:
Olmesartan medoxomil
Sponsor
Virginia Polytechnic Institute and State University
Collaborators
[object Object]